Huber Capital Management Stake in Pfizer (PFE) Has Cut by $4.37 Million as Share Price Rose …

… PRODUCT OFFICER/DEVICES; 30/04/2018 – Lightspeed Venture Partners Says Microsoft Chairman John Thompson Joining as a Venture Partner; …

Pfizer Inc. (NYSE:PFE) Logo

Davis Selected Advisers decreased its stake in Microsoft Corp. (MSFT) by 8.96% based on its latest 2018Q3 regulatory filing with the SEC. Davis Selected Advisers sold 291,651 shares as the company’s stock declined 1.64% with the market. The institutional investor held 2.96 million shares of the prepackaged software company at the end of 2018Q3, valued at $338.96 million, down from 3.26M at the end of the previous reported quarter. Davis Selected Advisers who had been investing in Microsoft Corp. for a number of months, seems to be less bullish one the $830.29 billion market cap company. The stock increased 1.23% or $1.32 during the last trading session, reaching $108.22. About 26.61 million shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 30.43% since February 17, 2018 and is uptrending. It has outperformed by 30.43% the S&P500. Some Historical MSFT News: 19/04/2018 – Ecolab Launches Cleanroom Portfolio in North America; 29/03/2018 – MICROSOFT NAMES PANOS PANAY CHIEF PRODUCT OFFICER/DEVICES; 30/04/2018 – Lightspeed Venture Partners Says Microsoft Chairman John Thompson Joining as a Venture Partner; 31/05/2018 – Ciena Announces Intent to Acquire Packet Design; 11/04/2018 – Commvault Expands Microsoft Azure Stack Integration; 20/03/2018 – Source-to-Pay Pioneer Determine, Inc. Brings the Power of eProcurement to SIG Global Executive Summit in Washington, DC; 21/05/2018 – Brightcove Pushes the Envelope with Video Experiences that Increase Customer ROI; 17/04/2018 – Anomali Partners with Visa to Offer Global Payment Breach Intelligence; 07/03/2018 – ChannelNet Launches OneClick Financial for Banks and Credit Unions; 17/04/2018 – MICROSOFT: 34 COMPANIES SIGN TECH ACCORD

Huber Capital Management Llc decreased its stake in Pfizer Inc (PFE) by 16.96% based on its latest 2018Q3 regulatory filing with the SEC. Huber Capital Management Llc sold 99,400 shares as the company’s stock rose 5.56% while stock markets declined. The hedge fund held 486,600 shares of the health care company at the end of 2018Q3, valued at $21.44M, down from 586,000 at the end of the previous reported quarter. Huber Capital Management Llc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $245.09 billion market cap company. The stock increased 1.02% or $0.43 during the last trading session, reaching $42.4. About 18.19 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 25.07% since February 17, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 23/03/2018 – Pfizer Reports Top-Line Results from a Study of CHANTIX®/CHAMPIX® (varenicline) in Adolescent Smokers; 17/03/2018 – New York Post: Burglars made off with Viagra in pharmacy heist; 15/05/2018 – U.S. FDA – RETACRIT HAS BEEN APPROVED AS A BIOSIMILAR, NOT AS AN INTERCHANGEABLE PRODUCT; 23/04/2018 – STAT Plus: Pharmalittle: Fresenius walks away from Akorn deal; FDA bounces a Pfizer biosimilar; 10/04/2018 – PFIZER – DMC’S RECOMMENDATION BASED ON AXITINIB STUDY FAILING TO DEMONSTRATE A CLEAR IMPROVEMENT IN PRIMARY ENDPOINT; 17/04/2018 – MERCK – FIRST STUDY TO EVALUATE PCV-15 FOLLOWED BY PNEUMOCOCCAL VACCINE POLYVALENT ONE YEAR LATER IN HEALTHY ADULTS 50 YEARS OF AGE OR OLDER; 21/03/2018 – PFIZER – POTENTIAL ALTERNATIVES FOR CONSUMER HEALTHCARE BUSINESS,INCLUDE SPIN-OFF,SALE OR OTHER TRANSACTION,AND PFIZER ULTIMATELY RETAINING BUSINESS; 17/05/2018 – PFIZER – RESULTS SHOWED ADJUNCTIVE TREATMENT WITH LYRICA 14 MG/KG/DAY RESULTED IN STATISTICALLY SIGNIFICANT REDUCTION IN SEIZURE FREQUENCY VS PLACEBO; 15/05/2018 – REXAHN PHARMACEUTICALS INC – SMC HAS CONFIRMED THAT COMBINATION OF RX-3117 AND ABRAXANE IS SAFE AND WELL TOLERATED; 12/04/2018 – PFIZER: CITI SEES PFE INCREASING SHARE REPURCHASE PROGRAM TO OFFSET EPS DILUTION FROM HIGHER ANTICIPATED R&D INVESTMENT TO MONETISE CURRENT PIPELINE

Since January 30, 2019, it had 0 insider buys, and 1 sale for $1.81 million activity.

Huber Capital Management Llc, which manages about $3.94 billion and $1.54B US Long portfolio, upped its stake in Royal Dutch Shell Plc by 23,800 shares to 362,408 shares, valued at $24.69 million in 2018Q3, according to the filing. It also increased its holding in Chesapeake Energy Corp (NYSE:CHK) by 3.49M shares in the quarter, for a total of 8.51 million shares, and has risen its stake in Tenet Healthcare Corp (NYSE:THC).

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Seekingalpha.com which released: “Pfizer recalls contaminated high blood pressure drug in Japan – Seeking Alpha” on February 08, 2019, also Seekingalpha.com with their article: “Pfizer Biopharmaceuticals Group’s Late-Stage Pipeline Looks Well Positioned – Seeking Alpha” published on February 06, 2019, Streetinsider.com published: “Pfizer Inc. (PFE) and Astellas Announce Phase 3 ARCHES Trial Shows XTANDI Significantly Improved Radiographic PFS in Men with Metastatic Hormone-Sensitive Prostate Cancer – StreetInsider.com” on February 11, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Pfizer: Still A Cash Cow – Seeking Alpha” published on January 22, 2019 as well as Streetinsider.com‘s news article titled: “EMD Seron, Pfizer (PFE) Announce FDA Accepted sBLA and Granted Priority Review for BAVENCIO Plus INLYTA for Treatment of Advanced RCC – StreetInsider.com” with publication date: February 11, 2019.

Among 23 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 13 Hold. Therefore 39% are positive. Pfizer had 92 analyst reports since July 29, 2015 according to SRatingsIntel. Societe Generale initiated Pfizer Inc. (NYSE:PFE) on Wednesday, April 6 with “Hold” rating. The stock of Pfizer Inc. (NYSE:PFE) has “Overweight” rating given on Thursday, August 23 by Morgan Stanley. As per Tuesday, December 1, the company rating was initiated by Barclays Capital. Barclays Capital maintained Pfizer Inc. (NYSE:PFE) on Thursday, August 23 with “Equal-Weight” rating. Jefferies maintained the shares of PFE in report on Monday, October 16 with “Hold” rating. The rating was maintained by SunTrust on Monday, October 16 with “Hold”. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Tuesday, October 31 by Piper Jaffray. On Tuesday, November 21 the stock rating was maintained by BMO Capital Markets with “Buy”. The company was maintained on Wednesday, January 31 by Credit Suisse. As per Friday, August 28, the company rating was maintained by Piper Jaffray.

Investors sentiment increased to 0.85 in Q3 2018. Its up 0.07, from 0.78 in 2018Q2. It is positive, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. Letko Brosseau & Assocs Inc invested 1.18% of its portfolio in Pfizer Inc. (NYSE:PFE). Massachusetts Fincl Svcs Company Ma has 1.09% invested in Pfizer Inc. (NYSE:PFE) for 60.13 million shares. West Coast Financial invested in 4,990 shares. John G Ullman & Assoc stated it has 3.6% in Pfizer Inc. (NYSE:PFE). Peloton Wealth Strategists owns 50,900 shares. Principal Fin Grp reported 15.29M shares. Srb holds 0.06% or 13,112 shares in its portfolio. Mackenzie Fincl reported 3.10 million shares or 0.33% of all its holdings. Ironwood Financial Lc accumulated 1,167 shares. Sawgrass Asset Management Limited Com holds 14,479 shares. Old Bankshares In owns 260,832 shares. Hutchinson Capital Management Ca has invested 0.62% in Pfizer Inc. (NYSE:PFE). Moors And Cabot holds 215,044 shares or 1.16% of its portfolio. Hall Laurie J Trustee stated it has 37,389 shares or 0.87% of all its holdings. 21,473 are owned by At Commercial Bank.

Investors sentiment decreased to 0.81 in 2018 Q3. Its down 0.03, from 0.84 in 2018Q2. It fall, as 33 investors sold MSFT shares while 981 reduced holdings. 145 funds opened positions while 681 raised stakes. 5.28 billion shares or 0.60% less from 5.31 billion shares in 2018Q2 were reported. Moreover, North Point Port Managers Corporation Oh has 0.09% invested in Microsoft Corporation (NASDAQ:MSFT) for 4,566 shares. Brave Asset Mngmt Incorporated has 48,010 shares. Mngmt Ltd Liability stated it has 0.05% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Canal Insur invested in 132,000 shares or 4.69% of the stock. Hanson & Doremus Inv Mgmt accumulated 57,563 shares or 2.06% of the stock. Steinberg Glob Asset Mgmt reported 0.68% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Minnesota-based Next Century Growth Investors Lc has invested 0.37% in Microsoft Corporation (NASDAQ:MSFT). Northstar Group has 0.31% invested in Microsoft Corporation (NASDAQ:MSFT). Moreover, Huntington Bancorporation has 2.12% invested in Microsoft Corporation (NASDAQ:MSFT) for 1.19M shares. Patriot Wealth Mngmt, a Texas-based fund reported 176,240 shares. Blue Chip Partners Inc owns 139,658 shares. Mawer Mgmt Ltd holds 0.33% in Microsoft Corporation (NASDAQ:MSFT) or 384,422 shares. Matarin Capital Mgmt Ltd Limited Liability Company holds 0% or 24,931 shares in its portfolio. New York-based Bluefin Trading Llc has invested 0.02% in Microsoft Corporation (NASDAQ:MSFT). Baker Avenue Asset Lp reported 181,123 shares or 1.71% of all its holdings.

Davis Selected Advisers, which manages about $48.17 billion and $23.26B US Long portfolio, upped its stake in Brixmor Property Group Inc. (NYSE:BRX) by 33,680 shares to 558,471 shares, valued at $9.78 million in 2018Q3, according to the filing. It also increased its holding in Camden Property Trust (NYSE:CPT) by 13,842 shares in the quarter, for a total of 177,703 shares, and has risen its stake in Prologis Inc. (NYSE:PLD).

More notable recent Microsoft Corporation (NASDAQ:MSFT) news were published by: Nasdaq.com which released: “Alibaba’s Cloud Business Is a Game-Changer – Nasdaq” on February 06, 2019, also Nasdaq.com with their article: “Technology Sector Update for 01/23/2019: IBM, TEL, TDY, MSFT, AAPL, GOOG, CSCO – Nasdaq” published on January 23, 2019, Nasdaq.com published: “Notable ETF Inflow Detected – QQQ, AAPL, MSFT, INTC – Nasdaq” on February 07, 2019. More interesting news about Microsoft Corporation (NASDAQ:MSFT) were released by: Seekingalpha.com and their article: “Microsoft acquires open-source software company – Seeking Alpha” published on January 24, 2019 as well as Nasdaq.com‘s news article titled: “Microsoft (MSFT) 2nd Quarter Earnings: What to Expect – Nasdaq” with publication date: January 30, 2019.

Among 38 analysts covering Microsoft Corporation (NASDAQ:MSFT), 34 have Buy rating, 1 Sell and 3 Hold. Therefore 89% are positive. Microsoft Corporation had 217 analyst reports since July 22, 2015 according to SRatingsIntel. Raymond James maintained Microsoft Corporation (NASDAQ:MSFT) on Friday, July 21 with “Buy” rating. The stock has “Buy” rating by Credit Suisse on Monday, August 7. As per Wednesday, June 13, the company rating was maintained by UBS. On Wednesday, December 20 the stock rating was maintained by Oppenheimer with “Buy”. The rating was maintained by Stifel Nicolaus with “Buy” on Friday, April 27. The stock has “Outperform” rating by Cowen & Co on Tuesday, May 24. The firm has “Buy” rating by RBC Capital Markets given on Monday, May 29. The rating was maintained by Wells Fargo on Friday, July 20 with “Outperform”. The rating was maintained by Bernstein on Thursday, May 24 with “Buy”. The firm has “Neutral” rating given on Tuesday, April 26 by Macquarie Research.

Since August 31, 2018, it had 0 buys, and 11 selling transactions for $82.43 million activity. On Friday, August 31 Hood Amy sold $13.09M worth of Microsoft Corporation (NASDAQ:MSFT) or 118,000 shares. 267,466 shares were sold by Nadella Satya, worth $28.35M. $422,000 worth of Microsoft Corporation (NASDAQ:MSFT) was sold by Capossela Christopher C. BROD FRANK H had sold 20,000 shares worth $2.15M on Wednesday, October 31.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Related Posts:

  • No Related Posts

Pfizer (PFE) Shareholder Jones Collombin Investment Counsel Boosted Stake; Baupost Group …

Jones Collombin Investment Counsel Inc increased its stake in Pfizer Inc (PFE) by 11.33% based on its latest 2018Q3 regulatory filing with the SEC.

McKesson Corporation (NYSE:MCK) Logo

Jones Collombin Investment Counsel Inc increased its stake in Pfizer Inc (PFE) by 11.33% based on its latest 2018Q3 regulatory filing with the SEC. Jones Collombin Investment Counsel Inc bought 28,145 shares as the company’s stock rose 5.56% while stock markets declined. The institutional investor held 276,622 shares of the health care company at the end of 2018Q3, valued at $12.19M, up from 248,477 at the end of the previous reported quarter. Jones Collombin Investment Counsel Inc who had been investing in Pfizer Inc for a number of months, seems to be bullish on the $245.09 billion market cap company. The stock increased 1.02% or $0.43 during the last trading session, reaching $42.4. About 18.19M shares traded. Pfizer Inc. (NYSE:PFE) has risen 25.07% since February 17, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 24/05/2018 – The settlement announced by the U.S. Department of Justice resolves allegations that Pfizer violated the federal False Claims Act between 2012 and 2016; 29/03/2018 – PFIZER INC – STUDY MET ITS PRIMARY ENDPOINT; 01/05/2018 – PFIZER: PDL1 IS BIOMARKER WITH ‘SOLID DATA’ FOR PFS AND OS; 15/05/2018 – Rexahn Pharm: SMC Confirmed Combination of RX-3117 and Abraxane Is Safe and Well Tolerated; 19/03/2018 – Pfizer at Investor Day Hosted By H.C. Wainwright Today; 17/04/2018 – POSITIVE RESULTS WITH DIVITUM® FROM NEW PFIZER STUDY PRESENTED AT THE AACR CONGRESS; 25/05/2018 – IMFINZI(R) (Durvalumab) Significantly Improves Overall Survival in the Phase III Pacific Trial for Unresectable Stage III Non-Small Cell Lung Cancer; 23/03/2018 – PFIZER INC – STUDY DID NOT MEET ITS PRIMARY ENDPOINT; 03/04/2018 – Pfizer in talks with P&G on sale of its consumer business, though far apart on price; 23/04/2018 – Pfizer: Additional Info Doesn’t Relate to Safety or Clinical Data Submitted in Biologics License Application

Baupost Group Llc increased its stake in Mckesson Corp (MCK) by 33.67% based on its latest 2018Q3 regulatory filing with the SEC. Baupost Group Llc bought 548,000 shares as the company’s stock declined 5.57% with the market. The hedge fund held 2.18M shares of the other pharmaceuticals company at the end of 2018Q3, valued at $288.61 million, up from 1.63 million at the end of the previous reported quarter. Baupost Group Llc who had been investing in Mckesson Corp for a number of months, seems to be bullish on the $26.00B market cap company. The stock increased 0.87% or $1.17 during the last trading session, reaching $135.56. About 1.07 million shares traded. McKesson Corporation (NYSE:MCK) has declined 17.94% since February 17, 2018 and is downtrending. It has underperformed by 17.94% the S&P500. Some Historical MCK News: 15/05/2018 – McKesson High Volume Solutions and Discount Drug Mart Partner to Build a Central Fill Pharmacy; 07/05/2018 – ROBBINS:ROBBINS SAID ADDED TO MCKESSON POSITION IN RECENT WEEKS; 24/04/2018 – McKesson and PrescribeWellness Announce Five-Year Partnership to Provide VaccineComplete and Expanded Access to Collaborative Practice Agreements; 05/04/2018 – McKesson Specialty Health Partners with CoverMyMeds to Deliver Keynote Address at eyeforpharma Philadelphia 2018; 25/04/2018 – STAT Plus: McKesson board exonerates execs from opioid crisis, but the Teamsters cry foul; 16/04/2018 – Cardinal Health and McKesson are among the companies that have been seen as vulnerable to Amazon’s entry into health care; 04/04/2018 – McKesson Specialty Health and CoverMyMeds Launch ExpressCoverage™, an Integrated eServices Platform Designed to Improve the Patient Care Journey; 25/04/2018 – McKesson: Growth Priorities Include New Offerings to Strengthen, Expand Role of Retail Pharmacy in Patient Care Delivery; 30/04/2018 – McKesson Bd of Directors Elects Brad Lerman as New Independent Director; 24/05/2018 – McKesson 4Q Loss $1.15B

Investors sentiment increased to 0.85 in 2018 Q3. Its up 0.07, from 0.78 in 2018Q2. It is positive, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. Shine Investment Advisory Serv Inc, a Colorado-based fund reported 5,185 shares. Patriot Wealth Mngmt holds 1.35% or 243,476 shares in its portfolio. Mastrapasqua Asset Mngmt Inc, a Tennessee-based fund reported 24,917 shares. Telemus Lc holds 0.24% in Pfizer Inc. (NYSE:PFE) or 72,129 shares. 1St Source State Bank holds 0.5% of its portfolio in Pfizer Inc. (NYSE:PFE) for 142,314 shares. Becker Management holds 1.58 million shares or 2.21% of its portfolio. Usca Ria Ltd Liability Corp reported 1.24% in Pfizer Inc. (NYSE:PFE). Salzhauer Michael invested in 0.1% or 5,988 shares. Forward Mgmt Lc accumulated 34,157 shares or 0.25% of the stock. Rmb Capital Limited stated it has 166,304 shares. Driehaus Mngmt Ltd Liability invested in 8,194 shares. Mraz Amerine Assocs Inc holds 9,968 shares. Signature Mgmt, a Virginia-based fund reported 71,026 shares. Sigma Planning, Michigan-based fund reported 141,816 shares. 493,267 are held by Clifford Swan Invest Counsel Ltd Liability Co.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Streetinsider.com which released: “Pfizer (PFE) Tops Q4 EPS by 1c, FY EPS Guidance Misses Consensus – StreetInsider.com” on January 29, 2019, also Seekingalpha.com with their article: “Pfizer Q4 2018 Earnings Preview – Seeking Alpha” published on January 28, 2019, Seekingalpha.com published: “Pfizer: Strong Buy Heading Into 2019 – Seeking Alpha” on January 30, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Streetinsider.com and their article: “EMD Seron, Pfizer (PFE) Announce FDA Accepted sBLA and Granted Priority Review for BAVENCIO Plus INLYTA for Treatment of Advanced RCC – StreetInsider.com” published on February 11, 2019 as well as Seekingalpha.com‘s news article titled: “Pfizer: Still A Cash Cow – Seeking Alpha” with publication date: January 22, 2019.

Jones Collombin Investment Counsel Inc, which manages about $290.33M US Long portfolio, decreased its stake in At&T Inc (NYSE:T) by 80,451 shares to 16,717 shares, valued at $561,000 in 2018Q3, according to the filing. It also reduced its holding in Facebook Inc (NASDAQ:FB) by 22,882 shares in the quarter, leaving it with 32,389 shares, and cut its stake in General Dynamics Corp (NYSE:GD).

Since January 30, 2019, it had 0 insider buys, and 1 insider sale for $1.81 million activity.

Among 23 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 13 Hold. Therefore 39% are positive. Pfizer had 92 analyst reports since July 29, 2015 according to SRatingsIntel. BMO Capital Markets downgraded the stock to “Market Perform” rating in Thursday, November 1 report. As per Thursday, April 7, the company rating was maintained by Jefferies. The rating was maintained by Jefferies with “Hold” on Wednesday, August 16. SunTrust maintained the shares of PFE in report on Monday, October 16 with “Hold” rating. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Monday, July 10 by Cowen & Co. On Wednesday, November 2 the stock rating was downgraded by Argus Research to “Hold”. The firm earned “Overweight” rating on Thursday, August 23 by Morgan Stanley. The rating was maintained by UBS with “Buy” on Wednesday, November 1. The stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given on Monday, October 16 by Jefferies. The company was downgraded on Tuesday, December 11 by JP Morgan.

Among 22 analysts covering McKesson Corporation (NYSE:MCK), 11 have Buy rating, 1 Sell and 10 Hold. Therefore 50% are positive. McKesson Corporation had 92 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was downgraded by Raymond James to “Mkt Perform” on Tuesday, January 12. The stock has “Mkt Perform” rating by Leerink Swann on Friday, October 28. The stock of McKesson Corporation (NYSE:MCK) has “Hold” rating given on Tuesday, April 4 by Needham. The company was maintained on Tuesday, August 29 by Jefferies. The stock of McKesson Corporation (NYSE:MCK) has “Equal-Weight” rating given on Tuesday, July 3 by Morgan Stanley. The firm has “Hold” rating given on Tuesday, April 26 by Standpoint Research. The stock has “Hold” rating by Mizuho on Wednesday, January 24. The firm has “Buy” rating by Standpoint Research given on Tuesday, July 10. On Monday, September 26 the stock rating was maintained by Mizuho with “Neutral”. As per Friday, October 28, the company rating was upgraded by Standpoint Research.

More notable recent McKesson Corporation (NYSE:MCK) news were published by: Seekingalpha.com which released: “FDA warns McKesson over opioid supply chain – Seeking Alpha” on February 12, 2019, also Seekingalpha.com with their article: “McKesson Q3 2018 Earnings Preview – Seeking Alpha” published on January 30, 2019, Seekingalpha.com published: “McKesson FQ3 sales up 5% – Seeking Alpha” on January 31, 2019. More interesting news about McKesson Corporation (NYSE:MCK) were released by: Seekingalpha.com and their article: “McKesson: Homing In On A Bottom – Seeking Alpha” published on December 17, 2018 as well as Seekingalpha.com‘s news article titled: “McKesson Corporation 2019 Q3 – Results – Earnings Call Slides – Seeking Alpha” with publication date: January 31, 2019.

Baupost Group Llc, which manages about $29.88B and $13.01B US Long portfolio, decreased its stake in Cardinal Health Inc (NYSE:CAH) by 361,515 shares to 4.74M shares, valued at $255.88M in 2018Q3, according to the filing.

Investors sentiment decreased to 0.71 in 2018 Q3. Its down 0.34, from 1.05 in 2018Q2. It dropped, as 59 investors sold MCK shares while 296 reduced holdings. 76 funds opened positions while 176 raised stakes. 162.62 million shares or 5.64% less from 172.34 million shares in 2018Q2 were reported. Apg Asset Management Nv invested 0.01% of its portfolio in McKesson Corporation (NYSE:MCK). Country Tru National Bank reported 7 shares. Bridgeway Management Inc stated it has 363,250 shares. 165,981 were reported by Chevy Chase Trust Hldg Inc. Culbertson A N & holds 34,175 shares or 1.24% of its portfolio. 242 were reported by Motco. Peapack Gladstone Fin Corp invested in 0.07% or 10,248 shares. First Personal reported 0.14% in McKesson Corporation (NYSE:MCK). Alliancebernstein Ltd Partnership holds 924,445 shares or 0.08% of its portfolio. 2.04 million are owned by Kiltearn Prns Llp. Moreover, Meeder Asset Mngmt has 0.01% invested in McKesson Corporation (NYSE:MCK). Personal Cap Advsr holds 0% or 1,635 shares in its portfolio. Gsa Capital Llp invested in 0.08% or 10,995 shares. Da Davidson accumulated 0% or 1,531 shares. Sterling Cap Ltd Liability Corp has invested 0.52% of its portfolio in McKesson Corporation (NYSE:MCK).

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

As Intel (INTC) Market Valuation Rose, Signature Estate & Investment Advisors Cut Its Stake by …

… 23/05/2018 – C3 IoT Partners With Intel to Deliver AI Appliance; 27/04/2018 – As of Friday open, Intel was up 20 percent on the year and nearly 50 …

Pfizer Inc. (NYSE:PFE) Logo

Signature Estate & Investment Advisors Llc decreased its stake in Intel Corp (INTC) by 94.36% based on its latest 2018Q3 regulatory filing with the SEC. Signature Estate & Investment Advisors Llc sold 56,408 shares as the company’s stock rose 1.97% while stock markets declined. The institutional investor held 3,369 shares of the semiconductors company at the end of 2018Q3, valued at $159,000, down from 59,777 at the end of the previous reported quarter. Signature Estate & Investment Advisors Llc who had been investing in Intel Corp for a number of months, seems to be less bullish one the $232.32B market cap company. The stock increased 1.67% or $0.85 during the last trading session, reaching $51.66. About 22.52M shares traded. Intel Corporation (NASDAQ:INTC) has risen 9.59% since February 17, 2018 and is uptrending. It has outperformed by 9.59% the S&P500. Some Historical INTC News: 23/05/2018 – Stratus Named AVEVA’s 2017 Technology Partner Product of the Year; 03/05/2018 – The Big Interview: Intel’s AI Chief Says Chip Giant “Has to Shift”; 23/05/2018 – C3 IoT Partners With Intel to Deliver AI Appliance; 27/04/2018 – As of Friday open, Intel was up 20 percent on the year and nearly 50 percent in the 12-month period; 26/04/2018 – INTEL CORP SEES FY NON-GAAP EPS $3.85, +/- 5%; 28/03/2018 – G-7 MINISTERS ISSUE STATEMENTS ON INNOVATION, ARTIFICIAL INTEL; 18/04/2018 – Investor Intel: Global Blockchain Introduces the Laser Network – The SWIFT for Blockchains; 26/04/2018 – INTEL CORP – KELLER WILL OFFICIALLY START IN HIS NEW ROLE AT CO ON APRIL 30; 19/03/2018 – Intel: Lavizzo-Mourey is Fifth New Independent Director Added to Intel’s Bd Since Beginning of 2016; 21/03/2018 – U.S. SENATE INTEL CHAIRMAN BURR SAYS NEED FOR U.S. ELECTION SECURITY IS ‘URGENT,’ FIXES TODAY MAY NOT BE IN TIME TO SAVE SYSTEM FOR 2020

Oakworth Capital Inc decreased its stake in Pfizer Inc (PFE) by 30.92% based on its latest 2018Q3 regulatory filing with the SEC. Oakworth Capital Inc sold 59,499 shares as the company’s stock rose 5.56% while stock markets declined. The institutional investor held 132,901 shares of the health care company at the end of 2018Q3, valued at $5.86M, down from 192,400 at the end of the previous reported quarter. Oakworth Capital Inc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $245.09B market cap company. The stock increased 1.02% or $0.43 during the last trading session, reaching $42.4. About 18.19 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 25.07% since February 17, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 07/05/2018 – Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma; 23/04/2018 – Pfizer hits stumbling block on Herceptin rival, but wins breakthrough status on MenB vaccine $PFE @BrittanyMeiling; 25/05/2018 – IMFINZI® (Durvalumab) Significantly Improves Overall Survival in the Phase lll Pacific Trial for Unresectable Stage lll Non-Small Cell Lung Cancer; 24/05/2018 – DOJ: Pfizer to Resolve Claims It Used Foundation as Conduit to Pay Copays of Medicare Patients Taking Three Pfizer Drugs; 23/03/2018 – Pfizer Reports Top-Line Results from a Study of CHANTIX®/CHAMPIX® (varenicline) in Adolescent Smokers; 11/04/2018 – PFIZER INC PFE.N : BERENBERG RAISES TARGET PRICE TO $37 FROM $36; 01/05/2018 – Pfizer Sees FY Rev $53.5B-$55.5B; 22/05/2018 – Spark Therapeutics and Pfizer Announce Data from 15 Participants with Hemophilia B Showing Persistent and Sustained Factor IX Levels with No Serious Adverse Events; 07/05/2018 – PFIZER INDIA QTR NET 1.05B RUPEES; EST. 854M RUPEES; 19/03/2018 – Pfizer at Investor Day Hosted By H.C. Wainwright Today

Since January 30, 2019, it had 0 insider buys, and 1 sale for $1.81 million activity.

Among 23 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 13 Hold. Therefore 39% are positive. Pfizer had 92 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Hold” rating by Argus Research given on Wednesday, November 2. As per Friday, December 2, the company rating was initiated by Guggenheim. The stock of Pfizer Inc. (NYSE:PFE) has “Neutral” rating given on Wednesday, November 25 by Suntrust Robinson. Argus Research maintained Pfizer Inc. (NYSE:PFE) on Wednesday, July 29 with “Buy” rating. As per Thursday, October 19, the company rating was maintained by BMO Capital Markets. The stock has “Buy” rating by Jefferies on Thursday, August 4. The stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given on Thursday, October 13 by Jefferies. The rating was maintained by BMO Capital Markets on Tuesday, August 1 with “Hold”. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) on Wednesday, August 2 with “Buy” rating. The firm has “Overweight” rating by Barclays Capital given on Tuesday, November 29.

Investors sentiment increased to 0.85 in Q3 2018. Its up 0.07, from 0.78 in 2018Q2. It improved, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. Zevin Asset Mgmt Ltd accumulated 9,210 shares. Voya Inv Management Limited Liability Corporation has invested 0.79% in Pfizer Inc. (NYSE:PFE). Bp Plc holds 1% or 743,000 shares. Conning Incorporated has 1.65% invested in Pfizer Inc. (NYSE:PFE) for 1.27 million shares. Macquarie Grp Ltd holds 24.20M shares or 1.74% of its portfolio. Augustine Asset Mgmt holds 0.99% of its portfolio in Pfizer Inc. (NYSE:PFE) for 40,535 shares. Eidelman Virant Cap owns 21,600 shares for 0.47% of their portfolio. Appleton Inc Ma reported 41,247 shares or 0.24% of all its holdings. Moreover, Buckhead Capital Mgmt Lc has 3.01% invested in Pfizer Inc. (NYSE:PFE). Tdam Usa holds 1.14% of its portfolio in Pfizer Inc. (NYSE:PFE) for 455,899 shares. 1,164 are owned by Barnett Communications. Coastline Co has invested 0.71% of its portfolio in Pfizer Inc. (NYSE:PFE). Dodge & Cox stated it has 0.01% of its portfolio in Pfizer Inc. (NYSE:PFE). Waverton Inv Ltd has invested 0.33% in Pfizer Inc. (NYSE:PFE). Clarivest Asset Mgmt Limited Liability Co reported 254 shares.

Oakworth Capital Inc, which manages about $500.15 million US Long portfolio, upped its stake in Ishares Msci Eafe Etf (EFA) by 7,516 shares to 13,590 shares, valued at $924,000 in 2018Q3, according to the filing. It also increased its holding in Financial Spdr Etf (XLF) by 86,405 shares in the quarter, for a total of 124,782 shares, and has risen its stake in Total System Services Inc (NYSE:TSS).

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Seekingalpha.com which released: “Pfizer: Still A Cash Cow – Seeking Alpha” on January 22, 2019, also Seekingalpha.com with their article: “Pfizer Q4 2018 Earnings Preview – Seeking Alpha” published on January 28, 2019, Seekingalpha.com published: “Pfizer recalls contaminated high blood pressure drug in Japan – Seeking Alpha” on February 08, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Streetinsider.com and their article: “Pfizer Inc. (PFE) and Astellas Announce Phase 3 ARCHES Trial Shows XTANDI Significantly Improved Radiographic PFS in Men with Metastatic Hormone-Sensitive Prostate Cancer – StreetInsider.com” published on February 11, 2019 as well as Seekingalpha.com‘s news article titled: “Pfizer: Strong Buy Heading Into 2019 – Seeking Alpha” with publication date: January 30, 2019.

Signature Estate & Investment Advisors Llc, which manages about $1.11 billion US Long portfolio, upped its stake in Dxc Technology Co by 51,995 shares to 245,524 shares, valued at $22.96M in 2018Q3, according to the filing. It also increased its holding in Microsoft Corp (NASDAQ:MSFT) by 32,129 shares in the quarter, for a total of 38,574 shares, and has risen its stake in Spdr Index Shs Fds (GMM).

Among 57 analysts covering Intel Corporation (NASDAQ:INTC), 32 have Buy rating, 7 Sell and 18 Hold. Therefore 56% are positive. Intel Corporation had 304 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Friday, July 27 by Summit Insights Group. Bank of America maintained Intel Corporation (NASDAQ:INTC) on Wednesday, April 18 with “Buy” rating. Bank of America downgraded the shares of INTC in report on Friday, July 27 to “Neutral” rating. The rating was downgraded by Bernstein to “Underperform” on Monday, March 21. The stock of Intel Corporation (NASDAQ:INTC) has “Equal-Weight” rating given on Friday, June 22 by Morgan Stanley. The stock of Intel Corporation (NASDAQ:INTC) earned “Underperform” rating by Bernstein on Wednesday, March 1. As per Tuesday, December 13, the company rating was initiated by Loop Capital. RBC Capital Markets maintained it with “Hold” rating and $3700 target in Monday, June 5 report. Robert W. Baird maintained Intel Corporation (NASDAQ:INTC) on Monday, February 26 with “Buy” rating. The firm has “Sell” rating given on Wednesday, July 12 by Raymond James.

More notable recent Intel Corporation (NASDAQ:INTC) news were published by: Seekingalpha.com which released: “Intel: Not Necessarily Appealing, Amidst No More Growth – Seeking Alpha” on January 27, 2019, also Nasdaq.com with their article: “Semiconductor Earnings Scorecard: INTC, TXN, XLNX, LRCX, ASML – Nasdaq” published on February 01, 2019, Seekingalpha.com published: “Should Intel Buy Mellanox? – Seeking Alpha” on January 31, 2019. More interesting news about Intel Corporation (NASDAQ:INTC) were released by: Nasdaq.com and their article: “After Hours Most Active for Jan 24, 2019 : F, SBUX, CZR, INTC, S, PM, GOLD, ET, RF, AAPL, ADI, QQQ – Nasdaq” published on January 24, 2019 as well as Nasdaq.com‘s news article titled: “Intel (INTC) 4th Quarter Earnings: What to Expect – Nasdaq” with publication date: January 24, 2019.

Since August 20, 2018, it had 2 buys, and 9 selling transactions for $893,356 activity. $102,050 worth of Intel Corporation (NASDAQ:INTC) shares were sold by Rodgers Steven Ralph. SWAN ROBERT HOLMES bought 5,117 shares worth $247,155. The insider McBride Kevin Thomas sold 6,500 shares worth $295,945.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Related Posts:

  • No Related Posts

WINTON GROUP Ltd Has $714000 Stake in Pfizer Inc. (NYSE:PFE)

WINTON GROUP Ltd reduced its position in Pfizer Inc. (NYSE:PFE) by 42.5% in the 3rd quarter, according to the company in its most recent 13F filing …

Pfizer logoWINTON GROUP Ltd reduced its position in Pfizer Inc. (NYSE:PFE) by 42.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 16,204 shares of the biopharmaceutical company’s stock after selling 12,001 shares during the quarter. WINTON GROUP Ltd’s holdings in Pfizer were worth $714,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of PFE. Fort L.P. purchased a new position in Pfizer during the 2nd quarter valued at about $121,000. Smart Portfolios LLC raised its position in shares of Pfizer by 43.9% during the 2nd quarter. Smart Portfolios LLC now owns 3,935 shares of the biopharmaceutical company’s stock worth $143,000 after acquiring an additional 1,200 shares in the last quarter. Selective Wealth Management acquired a new stake in shares of Pfizer during the 3rd quarter worth about $155,000. Point72 Hong Kong Ltd raised its position in shares of Pfizer by 7,195.5% during the 2nd quarter. Point72 Hong Kong Ltd now owns 4,815 shares of the biopharmaceutical company’s stock worth $175,000 after acquiring an additional 4,749 shares in the last quarter. Finally, Drexel Morgan & Co. purchased a new position in shares of Pfizer in the 2nd quarter valued at approximately $200,000. 70.61% of the stock is owned by institutional investors and hedge funds.

PFE opened at $42.40 on Friday. The company has a market capitalization of $252.40 billion, a P/E ratio of 14.13, a price-to-earnings-growth ratio of 2.39 and a beta of 0.77. Pfizer Inc. has a 12 month low of $34.32 and a 12 month high of $46.47. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.15 and a current ratio of 1.43.

Pfizer (NYSE:PFE) last issued its quarterly earnings results on Tuesday, January 29th. The biopharmaceutical company reported $0.64 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.01. The company had revenue of $13.98 billion for the quarter, compared to the consensus estimate of $13.92 billion. Pfizer had a return on equity of 25.38% and a net margin of 20.79%. The firm’s revenue was up 2.0% compared to the same quarter last year. During the same period last year, the business posted $0.62 earnings per share. As a group, research analysts expect that Pfizer Inc. will post 2.86 earnings per share for the current fiscal year.

Pfizer declared that its Board of Directors has authorized a share buyback program on Friday, December 14th that authorizes the company to repurchase $10.00 billion in shares. This repurchase authorization authorizes the biopharmaceutical company to purchase up to 3.8% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its shares are undervalued.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 1st. Shareholders of record on Friday, February 1st will be issued a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 3.40%. This is an increase from Pfizer’s previous quarterly dividend of $0.34. The ex-dividend date is Thursday, January 31st. Pfizer’s payout ratio is presently 48.00%.

In other news, EVP Douglas M. Lankler sold 38,800 shares of Pfizer stock in a transaction that occurred on Wednesday, January 30th. The shares were sold at an average price of $41.19, for a total value of $1,598,172.00. Following the completion of the transaction, the executive vice president now owns 83,592 shares in the company, valued at $3,443,154.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Douglas M. Lankler sold 5,000 shares of Pfizer stock in a transaction that occurred on Friday, February 1st. The shares were sold at an average price of $42.75, for a total transaction of $213,750.00. Following the completion of the transaction, the executive vice president now owns 83,592 shares of the company’s stock, valued at approximately $3,573,558. The disclosure for this sale can be found here. 0.06% of the stock is currently owned by insiders.

Several research analysts have weighed in on PFE shares. JPMorgan Chase & Co. reiterated a “buy” rating on shares of Pfizer in a research note on Tuesday, October 30th. Cantor Fitzgerald reiterated a “buy” rating and set a $53.00 target price on shares of Pfizer in a research report on Monday, November 19th. Atlantic Securities reiterated a “buy” rating and issued a $54.00 target price on shares of Pfizer in a research note on Tuesday, November 27th. Argus upgraded Pfizer from a “hold” rating to a “buy” rating and set a $55.00 target price for the company in a research note on Thursday, January 31st. Finally, Credit Suisse Group set a $42.00 price target on Pfizer and gave the stock a “hold” rating in a research note on Monday, November 26th. Three analysts have rated the stock with a sell rating, thirteen have issued a hold rating and seven have issued a buy rating to the company. Pfizer presently has a consensus rating of “Hold” and a consensus target price of $44.68.

TRADEMARK VIOLATION WARNING: “WINTON GROUP Ltd Has $714,000 Stake in Pfizer Inc. (NYSE:PFE)” was reported by Modern Readers and is the property of of Modern Readers. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.modernreaders.com/news/2019/02/17/winton-group-ltd-trims-holdings-in-pfizer-inc-pfe.html.

Pfizer Profile

Pfizer Inc discovers, develops, manufactures, and sells healthcare products worldwide. It operates in two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as over-the-counter brands comprising dietary supplements, pain management, gastrointestinal, and respiratory and personal care.

See Also: Municipal Bonds

Institutional Ownership by Quarter for Pfizer (NYSE:PFE)

Receive News & Ratings for Pfizer Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Pfizer and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Pfizer (PFE) Shares Rose While Tower Bridge Advisors Decreased Its Holding; Newman Dignan …

… 01/05/2018 – Nlyte Software Teams With IBM’s Watson IoT to Leverage Machine Learning for Enhanced Data Center Operations; 23/05/2018 – IBM …

Pfizer Inc. (NYSE:PFE) Logo

Newman Dignan & Sheerar Inc increased its stake in International Business Machine (IBM) by 109.02% based on its latest 2018Q3 regulatory filing with the SEC. Newman Dignan & Sheerar Inc bought 2,115 shares as the company’s stock declined 16.83% with the market. The institutional investor held 4,055 shares of the computer manufacturing company at the end of 2018Q3, valued at $604,000, up from 1,940 at the end of the previous reported quarter. Newman Dignan & Sheerar Inc who had been investing in International Business Machine for a number of months, seems to be bullish on the $125.44B market cap company. The stock increased 1.14% or $1.55 during the last trading session, reaching $138.03. About 3.84M shares traded. International Business Machines Corporation (NYSE:IBM) has declined 21.12% since February 16, 2018 and is downtrending. It has underperformed by 21.12% the S&P500. Some Historical IBM News: 18/04/2018 – SiliconANGLE: IBM brings two key open-source developer tools together in its latest cloud service; 17/04/2018 – IBM – COMPANY EXPECTS FY 2018 GAAP DILUTED EARNINGS PER SHARE OF AT LEAST $11.58; 08/03/2018 – IBM: WILL REDUCE SHARE COUNT 2% ANNUALLY THROUGH BUYBACKS; 17/04/2018 – IBM – REPORTED GAAP AND OPERATING (NON-GAAP) TAX RATES FOR THE FIRST QUARTER INCLUDE A $0.8 BILLION DISCRETE TAX BENEFIT; 20/03/2018 – Zerto Partners with IBM to Provide Data Protection for lBM’s Resiliency Orchestration DRaaS Solution; 01/05/2018 – Nlyte Software Teams With IBM’s Watson IoT to Leverage Machine Learning for Enhanced Data Center Operations; 23/05/2018 – IBM gives jobs boost to Emmanuel Macron’s pitch to tech groups; 27/03/2018 – Tech companies, like Amazon, Apple and IBM, all cover the surgery; 05/03/2018 – IBM settles legal dispute with diversity officer hired by Microsoft; 26/04/2018 – Jewelry companies team up with IBM on blockchain platform

Tower Bridge Advisors decreased its stake in Pfizer Inc (PFE) by 0.49% based on its latest 2018Q3 regulatory filing with the SEC. Tower Bridge Advisors sold 985 shares as the company’s stock rose 5.56% while stock markets declined. The institutional investor held 200,144 shares of the health care company at the end of 2018Q3, valued at $8.82 billion, down from 201,129 at the end of the previous reported quarter. Tower Bridge Advisors who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $245.09B market cap company. The stock increased 1.02% or $0.43 during the last trading session, reaching $42.4. About 18.19 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 25.07% since February 16, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 21/05/2018 – KARO PHARMA RECEIVES MILESTONE PAYMENT FOR RORGAMMA PROJECT FROM PFIZER; 11/05/2018 – eFFECTOR Initiates Randomized Dosing in Phase 2 Checkpoint Combination Trial of eFT508 and Avelumab in Colorectal Cancer; 01/05/2018 – Pfizer says it is not looking for a mega-deal; 10/04/2018 – Pfizer Provides Update on Phase 3 Trial of Axitinib as Adjuvant Treatment for Patients at High Risk of Renal Cell Carcinoma; 05/03/2018 – Dan R. Littman Elected to Pfizer’s Bd of Directors; 22/05/2018 – A Study Analyzing Observational Data Shows Real-World Effectiveness of Prevnar® 13 in Adults Age 65+; 19/04/2018 – ASEMBIA EXPANDS PACT WITH PFIZER ONCOLOGY; 09/05/2018 – PFIZER SAYS WORKING TO INCREASE EPIPEN PRODUCTION; 08/05/2018 – Mylan says EpiPen supply levels may vary at U.S. pharmacies; 18/05/2018 – ASTRAZENECA PLC AZN.L – OFFSET BY EROSION OF CRESTOR SALES

Investors sentiment increased to 0.91 in Q3 2018. Its up 0.01, from 0.9 in 2018Q2. It improved, as 65 investors sold IBM shares while 594 reduced holdings. 116 funds opened positions while 481 raised stakes. 492.69 million shares or 0.61% more from 489.70 million shares in 2018Q2 were reported. Amundi Pioneer Asset Management Inc holds 2.97 million shares or 0.59% of its portfolio. 2,060 are owned by Strategic Advsrs Ltd Limited Liability Company. Wealthtrust invested 0.01% of its portfolio in International Business Machines Corporation (NYSE:IBM). Fruth Investment Mgmt has 0.16% invested in International Business Machines Corporation (NYSE:IBM) for 2,586 shares. Sector Pension Invest Board holds 0.05% of its portfolio in International Business Machines Corporation (NYSE:IBM) for 42,921 shares. Logan Capital Management has 1.37% invested in International Business Machines Corporation (NYSE:IBM) for 138,596 shares. Fdx Advsr Inc accumulated 0.03% or 4,799 shares. Moreover, Wellington Shields Capital Management Lc has 0.42% invested in International Business Machines Corporation (NYSE:IBM). Carret Asset Management Limited Liability owns 32,915 shares. Roberts Glore & Il reported 0.15% stake. Moreover, Oppenheimer Asset Inc has 0.41% invested in International Business Machines Corporation (NYSE:IBM). Sabal Com holds 0.03% or 2,267 shares. 555,127 are owned by Fort Washington Inv Incorporated Oh. Sigma Planning reported 0.16% in International Business Machines Corporation (NYSE:IBM). Lee Danner & Bass holds 0.34% or 22,819 shares in its portfolio.

Among 35 analysts covering International Business Machines (NYSE:IBM), 14 have Buy rating, 5 Sell and 16 Hold. Therefore 40% are positive. International Business Machines had 142 analyst reports since July 21, 2015 according to SRatingsIntel. BMO Capital Markets maintained International Business Machines Corporation (NYSE:IBM) rating on Friday, January 19. BMO Capital Markets has “Hold” rating and $175.0 target. The rating was maintained by Argus Research with “Buy” on Friday, July 21. Bernstein maintained International Business Machines Corporation (NYSE:IBM) rating on Wednesday, April 12. Bernstein has “Market Perform” rating and $150 target. As per Friday, January 19, the company rating was maintained by Berenberg. The stock has “Sell” rating by Societe Generale on Friday, January 19. The company was maintained on Monday, November 13 by RBC Capital Markets. RBC Capital Markets maintained it with “Hold” rating and $160.0 target in Thursday, August 31 report. The company was upgraded on Wednesday, January 3 by RBC Capital Markets. The stock has “Underperform” rating by Jefferies on Tuesday, July 19. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, January 12.

More notable recent International Business Machines Corporation (NYSE:IBM) news were published by: Seekingalpha.com which released: “Stocks To Watch: Earnings Heat Check – Seeking Alpha” on January 19, 2019, also Seekingalpha.com with their article: “IBM As A Dividend Investment – Seeking Alpha” published on January 28, 2019, Investorplace.com published: “5 Must-See Stock Charts for Thursday: ABT, IBM, SBUX, PZZA – Investorplace.com” on January 24, 2019. More interesting news about International Business Machines Corporation (NYSE:IBM) were released by: Fool.com and their article: “Forget IBM. Microsoft Is a Better Dividend Growth Stock – Motley Fool” published on January 27, 2019 as well as Finance.Yahoo.com‘s news article titled: “3 Top Artificial Intelligence Stocks to Watch in February – Yahoo Finance” with publication date: February 15, 2019.

Since October 31, 2018, it had 5 insider purchases, and 0 sales for $2.09 million activity. TAUREL SIDNEY bought $495,846 worth of International Business Machines Corporation (NYSE:IBM) on Wednesday, October 31. Another trade for 2,000 shares valued at $232,838 was made by Swedish Joseph on Thursday, November 1. Shares for $249,722 were bought by WADDELL FREDERICK H on Thursday, November 1. Another trade for 8,500 shares valued at $998,835 was bought by Rometty Virginia M.

Since January 30, 2019, it had 0 insider purchases, and 1 insider sale for $1.81 million activity.

Tower Bridge Advisors, which manages about $1.11B and $957.21B US Long portfolio, upped its stake in Synchrony Financial (NYSE:SYF) by 19,053 shares to 353,845 shares, valued at $11.00B in 2018Q3, according to the filing. It also increased its holding in Fulton Finl Corp Pa (NASDAQ:FULT) by 3,563 shares in the quarter, for a total of 15,785 shares, and has risen its stake in Toll Brothers Inc (NYSE:TOL).

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Seekingalpha.com which released: “Pfizer Q4 2018 Earnings Preview – Seeking Alpha” on January 28, 2019, also Streetinsider.com with their article: “Pfizer (PFE) Tops Q4 EPS by 1c, FY EPS Guidance Misses Consensus – StreetInsider.com” published on January 29, 2019, Streetinsider.com published: “EMD Seron, Pfizer (PFE) Announce FDA Accepted sBLA and Granted Priority Review for BAVENCIO Plus INLYTA for Treatment of Advanced RCC – StreetInsider.com” on February 11, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Pfizer: Strong Buy Heading Into 2019 – Seeking Alpha” published on January 30, 2019 as well as Seekingalpha.com‘s news article titled: “Pfizer recalls contaminated high blood pressure drug in Japan – Seeking Alpha” with publication date: February 08, 2019.

Investors sentiment increased to 0.85 in 2018 Q3. Its up 0.07, from 0.78 in 2018Q2. It increased, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. The Maryland-based Family Firm has invested 0.1% in Pfizer Inc. (NYSE:PFE). Moreover, Professional Advisory Svcs has 0.22% invested in Pfizer Inc. (NYSE:PFE). Koshinski Asset has 1.53% invested in Pfizer Inc. (NYSE:PFE) for 243,358 shares. Birch Hill Investment Advsrs Ltd Llc reported 0.18% of its portfolio in Pfizer Inc. (NYSE:PFE). Rockland Tru owns 168,550 shares. Moreover, Richard Bernstein Advisors Ltd has 0.3% invested in Pfizer Inc. (NYSE:PFE). Miller Inv Mngmt Limited Partnership has invested 0.39% of its portfolio in Pfizer Inc. (NYSE:PFE). Moreover, Comerica Financial Bank has 0.76% invested in Pfizer Inc. (NYSE:PFE). North American Corp stated it has 169,872 shares. Milestone Gp Inc invested 0.07% of its portfolio in Pfizer Inc. (NYSE:PFE). Mengis Capital Inc invested in 40,542 shares. Blue Finance Cap Inc owns 46,273 shares. Mackenzie Financial Corp holds 0.33% or 3.10M shares. 29,463 are owned by Warren Averett Asset Mngmt Lc. Hengehold Cap Mgmt Ltd Liability Company holds 0.89% or 80,717 shares.

Among 23 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 13 Hold. Therefore 39% are positive. Pfizer had 92 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Overweight” rating on Friday, August 28 by Piper Jaffray. The stock has “Hold” rating by Jefferies on Thursday, October 13. S&P Research maintained the stock with “Hold” rating in Wednesday, October 28 report. Goldman Sachs maintained the shares of PFE in report on Monday, April 18 with “Neutral” rating. The firm has “Buy” rating by Cowen & Co given on Monday, September 18. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) on Thursday, September 14 with “Buy” rating. Jefferies maintained the stock with “Buy” rating in Monday, June 20 report. BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) rating on Tuesday, November 21. BMO Capital Markets has “Buy” rating and $39.0 target. The firm has “Outperform” rating by BMO Capital Markets given on Thursday, October 19. The company was maintained on Wednesday, May 2 by BMO Capital Markets.

International Business Machines Corporation (NYSE:IBM) Institutional Positions Chart

Related Posts:

  • No Related Posts